Magle Group: We live by the mantra ‘earn it before you burn it’
Yesterday, Magle Group released their Q4 report showing a notable increase in revenue, underpinned by organic growth as well as the integration of two key acquisitions: PK Chemical and Amniotics. As the company continues to expand its footprint within specialty pharma and medtech, the latest quarter offers a glimpse into the early effects of these strategic moves. BioStock invited CFO Aaron Wong to the studio to tell us more about the report.
See the interview with Aaron Wong here.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
